Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Bone and soft tissue cancers Clinical Trials

Protocol Number Title
1999CG016
D9902 A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
2008NTCG058
COG AEWS07B1 A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens
2008NTCG085
COG AOST06B1 A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
2008NTCG101
COG ANBL00B1 "Neuroblastoma Biology Studies"
2009NTUC056
Childhood Cancer Survivor Study
2010NTLS054
Detection of Serum/Plasma miRNA in Sarcomas
2011CG024
COG AEWS1031 - A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
2011OC057
MT2011-09C Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients with High Risk or Relapsed Solid Tumor
2012IS046
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
2012LS107
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Refractory Neuroblastoma and Pheochromocytoma - A Best Available Therapy/Compassionate Use Protocol
2013CG094
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
2013UC074
Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial 2.Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer
2014CG064
COG ARST1321 - Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754, IND# 118613)
2014CG129
COG AEWS1221 - Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma

14 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on